临床试验中对品牌的实际使用。欧洲联盟法院(TJUE)对Viridis c. Hecht-Pharma的判决

2019年9月10日

By: Jorge Llevat

 

As we know, one of the principles of any trademark protection system is the use of the registered mark.  Failure to effectively use a trademark registered for products or services for five consecutive years is grounds for revocation (art. 58.1.a) EUTR).

The question of effective use of a trademark has been the subject of countless rulings that have examined the issue in a wide variety of areas, including clinical trials.

 

Continue reading at blog.cuatrecasas.com

分享: 
相关新闻